Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
BMS 777607
Cat No.
CEI-0069
Description
BMS 777607 can inhibit c-Met with IC50 of 20 nM.
CAS No.
1196681-44-3
Molecular Weight
512.89
Purity
>99%
Storage
2 years at -20centigrade Powder
Targets
c-Met
Molecular Formula
C25H19ClF2N4O4
Chemical Name
N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide
Solubility
DMSO 47 mg/mL Water
In vitro
BMS-777607 is a novel, selective, and orally available ATP-competitive Met kinase inhibitor that specifically targets several Met family members and potently binds to the c-Met active site with a Ki value of 3.9 nmol/L. BMS-777607 potently blocked the autophosphoryla-tion of c-Met with an IC 50 of 20 nmol/L. BMS-777607 can inhibit HGF-induced prostate cancer cell scattering, suppress HGF-induced cell migration, impair HGF-mediated cell invasion and reduce cell proliferation increased by HGF. BMS-777607 can also block HGF-stimulated c-Met downstream signaling pathway
In vivo
Oral administration of BMS 777607 (6.25-50 mg/kg) significantly reduces tumor volumes of the GTL-16 human tumor xenografts in athymic mice with no observed toxicity.
Download
Download Datasheet